Eurofins Launches the Second Tranche of a Buy-back Programme

Regulatory News: Eurofins (Paris:ERF): Following the announcement on 3 October 2022 to buy-back some of its own shares (ISIN FR0014000MR3) (the "Share Repurchase Plan") and the completion of the

Related Keywords

, Contract Research , European Parliament , Biopharma Contract Development , Euronext Paris Stock Exchange , Company Extraordinary , Company Long , Regulatory News , Eurofins Scientific , Share Repurchase Plan , Extraordinary General Meeting , Long Term Incentive , Eurofins , Aunches , Second , Tranche , Back , Programme , Hares ,